Novo Nordisk, Lilly, Sanofi Must Face Insulin Drug Pricing Suit

(Bloomberg) -- Novo Nordisk A/S and two other insulin makers must face claims they gouged diabetes patients through deceptive price lists for their life-saving drugs.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.